News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
853,930 Results
Type
Article (86966)
Company Profile (704)
Press Release (766259)
Multimedia
Podcasts (151)
Webinars (19)
Section
Business (232862)
Career Advice (4133)
Deals (39768)
Drug Delivery (130)
Drug Development (91130)
Employer Resources (199)
FDA (18207)
Job Trends (17369)
News (396935)
Policy (39837)
Tag
Academia (3002)
Academic (2)
Accelerated approval (13)
Adcomms (33)
Allergies (109)
Alliances (56975)
ALS (122)
Alzheimer's disease (1604)
Antibody-drug conjugate (ADC) (192)
Approvals (18157)
Artificial intelligence (405)
Autoimmune disease (39)
Automation (19)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (103)
Brain cancer (41)
Breast cancer (404)
Cancer (3192)
Cardiovascular disease (254)
Career advice (3542)
Career pathing (34)
CAR-T (213)
CDC (43)
Cell therapy (587)
Cervical cancer (25)
Clinical research (74458)
Collaboration (1149)
Company closure (3)
Compensation (732)
Complete response letters (37)
COVID-19 (2911)
CRISPR (69)
C-suite (384)
Cystic fibrosis (124)
Data (3218)
Decentralized trials (2)
Denatured (53)
Depression (81)
Diabetes (383)
Diagnostics (6992)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (190)
Drug pricing (155)
Drug shortages (36)
Duchenne muscular dystrophy (159)
Earnings (97729)
Editorial (50)
Employer branding (25)
Employer resources (169)
Events (131602)
Executive appointments (922)
FDA (20047)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1036)
Gene editing (151)
Generative AI (41)
Gene therapy (461)
GLP-1 (945)
Government (5281)
Grass and pollen (7)
Guidances (201)
Healthcare (20919)
HIV (46)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (191)
Immuno-oncology (13)
Indications (42)
Infectious disease (3115)
Inflammatory bowel disease (166)
Inflation Reduction Act (13)
Influenza (76)
Intellectual property (128)
Interviews (813)
IPO (17907)
IRA (57)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (59)
Layoffs (599)
Leadership (27)
Legal (10138)
Liver cancer (85)
Longevity (12)
Lung cancer (446)
Lymphoma (223)
Machine learning (12)
Management (65)
Manufacturing (476)
MASH (104)
Medical device (14747)
Medtech (14753)
Mergers & acquisitions (22606)
Metabolic disorders (977)
Multiple sclerosis (106)
NASH (23)
Neurodegenerative disease (163)
Neuropsychiatric disorders (46)
Neuroscience (2391)
NextGen: Class of 2025 (7687)
Non-profit (5091)
Now hiring (50)
Obesity (497)
Opinion (292)
Ovarian cancer (105)
Pain (127)
Pancreatic cancer (133)
Parkinson's disease (203)
Partnered (25)
Patents (330)
Patient recruitment (184)
Peanut (55)
People (65786)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22970)
Phase II (32330)
Phase III (24350)
Pipeline (1770)
Policy (250)
Postmarket research (3554)
Preclinical (10373)
Press Release (72)
Prostate cancer (156)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (542)
Real estate (7402)
Recruiting (76)
Regulatory (27306)
Reports (62)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (12)
RSV (61)
Schizophrenia (102)
Series A (174)
Series B (120)
Service/supplier (30)
Sickle cell disease (68)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (37)
Startups (4307)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (70)
The Weekly (96)
Vaccines (935)
Venture capital (60)
Weight loss (334)
Women's health (52)
Worklife (20)
Date
Today (134)
Last 7 days (545)
Last 30 days (1957)
Last 365 days (33896)
2025 (19469)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1276)
Alabama (72)
Alaska (7)
Arizona (281)
Arkansas (14)
Asia (50587)
Australia (8890)
California (7972)
Canada (2467)
China (739)
Colorado (342)
Connecticut (353)
Delaware (215)
Europe (116106)
Florida (1187)
Georgia (272)
Hawaii (3)
Idaho (67)
Illinois (756)
India (34)
Indiana (395)
Iowa (19)
Japan (245)
Kansas (117)
Kentucky (33)
Louisiana (19)
Maine (73)
Maryland (1126)
Massachusetts (6100)
Michigan (280)
Minnesota (498)
Mississippi (4)
Missouri (107)
Montana (32)
Nebraska (26)
Nevada (86)
New Hampshire (74)
New Jersey (2238)
New Mexico (31)
New York (2229)
North Carolina (1262)
North Dakota (10)
Northern California (3456)
Ohio (259)
Oklahoma (17)
Oregon (48)
Pennsylvania (1710)
Puerto Rico (18)
Rhode Island (40)
South America (1654)
South Carolina (36)
South Dakota (1)
Southern California (2962)
Tennessee (131)
Texas (1228)
United States (30089)
Utah (233)
Virginia (220)
Washington D.C. (80)
Washington State (703)
West Virginia (4)
Wisconsin (87)
There are 853,930 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
Exit Stage Right: With Prasad Out, Analysts Hope for More Traditional Replacement
As analysts parsed news of Vinay Prasad’s ouster, worries over drug approval delays, cell and gene therapy impacts and more were top of mind.
July 30, 2025
·
5 min read
·
Annalee Armstrong
Press Releases
TauGen Files US Patent Application for Innovative Drug Candidates Targeting Traumatic Brain Injury (TBI
July 30, 2025
·
1 min read
Layoff Tracker
Hookipa Winds Down, Merck Trims Billions in ‘Reallocation’
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
July 30, 2025
·
171 min read
·
BioSpace Editorial Staff
MASH
Madrigal Makes Potential $2B+ Bet for CSPC’s GLP-1 Pill
Madrigal will study SYH2086 in combination with Rezdiffra for metabolic dysfunction-associated steatohepatitis, aiming for clinical trials in early 2026.
July 30, 2025
·
2 min read
·
Tristan Manalac
Press Releases
BioMark Diagnostics Highlights Fiscal Year 2025 Achievements and Sets Bold Strategic Milestones for 2025 - 2026
July 30, 2025
·
5 min read
Press Releases
PharmaDrug Signs LOI to Acquire Equity Interest in Canurta Inc.
July 30, 2025
·
13 min read
Press Releases
Sharp Therapeutics Corp. Engages Rho Inc. to Help Advance Compounds into Clinical Trials for Gaucher Disease
July 30, 2025
·
5 min read
Press Releases
Embolization Particles Market Projected to Reach USD 3.79 Billion by 2034 at 12.27% CAGR
July 30, 2025
·
1 min read
Press Releases
Cell & Gene Therapy Contract Research Organizations Market Size to Surpass USD 13.76 Billion by 2034
July 30, 2025
·
1 min read
Press Releases
Biologics Market Size to Lead USD 1,126.96 Billion by 2034 Driven by Rising Demand for Advanced Therapies and Technological Advancements
July 30, 2025
·
1 min read
1 of 85,393
Next
